German media savages EU for vaccine shambles which it calls ‘an advert for Brexit’

German media today rounded on the EU over Europe’s vaccine debacle – calling it ‘the best advert for Brexit’ while blaming chief Ursula von der Leyen for a three-month delay in ordering jabs compared to the UK. 

The EU is acting ‘slowly, bureaucratically and protectionist… and if something goes wrong, it’s everyone else’s fault’ fumed a front-page editorial in Die Zeit, one of Germany’s best-respected broadsheets.

Meanwhile Bild tore apart Von Der Leyen’s explanation of the vaccine delays and threat to stop supplies heading to the UK line by line, accusing her of placing ‘junk’ orders for vaccines three months behind Britain.

‘She says: “We know that there is no time to lose in a pandemic,” but what she means is: “We may have wasted time. But we will NEVER admit that”‘. Meanwhile ‘Brexit Brits continue to receive full supplies,’ the paper added.

Both reports quoted an employee for vaccine-maker AstraZeneca, who said: ‘I understand Brexit a bit better now.’

Meanwhile Brexiteer MPs in the UK seized on the chaos to claim it proves they were right to split from the bloc while calling the delay in EU vaccine orders ‘absurd’.

Nigel Farage, the leader of the Reform UK Party, said the vaccines situation proved the EU is a ‘bad project, run by bad people’ and added: ‘Brexit was the right thing to do.’

The UK is vaccinating its population at one of the fastest rates in the world, and has jabbed more than any other country in Europe – leading to heavy criticism of the EU’s jab roll-out and accusations of vaccine theft from Brussels

Ursula Von Der Leyen, president of the European Commission, has been slammed by German media for placing 'junk' orders for vaccines three weeks later than the UK

Ursula Von Der Leyen, president of the European Commission, has been slammed by German media for placing ‘junk’ orders for vaccines three weeks later than the UK

Tory MP Peter Bone told MailOnline: ‘Do you remember the criticism we faced for not joining the EU vaccination programme?

‘We made the right call as an independent nation and it is clear it was a benefit to us not being tied to the bureaucracy of the EU. 

Matt Hancock reveals nearly 80% of UK over-80s have now had a Covid vaccine as NHS rollout reaches 6.6MILLION people 

Health Secretary Matt Hancock last night announced that 78.7 per cent of Britons over the age of 80 have had a Covid vaccine as he confirmed 6.6million people have received their first dose.

That means nearly one in 10 people across the country has had at least one dose that could protect them against deadly Covid-19, and the Government is nearly halfway through its drive to hit 15million by mid-February.

Britain is ahead of all other countries in Europe in its vaccine drive and has one of the highest per-person rates in the world. But a Sunday slowdown meant that only 221,067 people received vaccines, down from a record high of 493,013 people on Saturday.

Department of Health figures showed 220,249 first doses and 818 second doses were administered across the country on January 24.

The Sunday slowdown is thought to have been triggered by fewer doctors and nurses being on shift on the last day of the working week, meaning fewer Britons could receive their jabs. The smallest number of cases and deaths is also generally recorded on Sundays, when more staff are off work and unavailable to tick off reports.

It comes as ministers battle to vaccinate the most vulnerable to the virus by mid-February. This includes the over-70s, vulnerable, care home residents and NHS frontline staff.

But the NHS appears to have already missed its internal target of reaching all care home residents by January 24.

The Health Secretary Matt Hancock said last Thursday they had already vaccinated 63 per cent of care home residents – leaving another 154,660 out of an estimated 420,000 residents waiting for their jabs. But ministers are yet to say whether the NHS target has been hit.

Britain last night recorded another 22,195 infections with the virus, a 41 per cent drop on last week, and a further 592 deaths, down one per cent on the same time last week.

‘A three month delay is absurd. It is clearly an advantage to not be part of the EU and it is really good for us but sad obviously for the people of the countries of the EU.’

Adding to the criticism over the other side of the Channel, the Bild newspaper wrote: ‘Von Der Leyen said: “Few suspected [in 2020] that this was the beginning of a pandemic that would still be with us a year later.” 

‘What she means is: “Unfortunately, we are not one of the smart few…”

The paper concludes: ‘[Von Der Leyen] is responsible for EU junk orders. 

‘Also for the fact that the EU only reached an agreement with AstraZeneca in August, not in June – as [German health minister] Jens Spahn wanted but was not allowed to. Valuable preparation time passed.

‘Von der Leyen cannot do anything for the current audacity of AstraZeneca. The criticism is justified. But there must also be self-criticism.’

Meanwhile, Die Zeit added: ‘In the UK, the government’s independent and swift vaccination policy is seen as evidence that the EU is too bureaucratic and slow – and is now left behind.’

The criticism came as the CEO of AstraZeneca – the company which sparked the row by cutting EU vaccine supplies by 60 per cent – spoke out to defend himself, while also pointing the finger of blame at delays in Brussels.

Asked why supplies were being cut to the EU but not the recently-departed UK, Pascal Soriot said it had nothing to do with national favoritism and everything to do with the fact that the EU placed its vaccine order late.

‘We had problems in the UK too,’ he told a trio of European newspapers including Italy’s Repubblica on Tuesday.

‘But the contract with the British government was signed three months before the one with the EU, therefore we had time to prepare and resolve similar issues.

‘The UK and the EU have two different production chains and at the moment the British ones are more efficient because they started earlier.’ 

Britain signed a contract for 300million doses of vaccine in mid-May, he revealed, but it took the EU until August to put pen to paper on the same deal.

Embarrassingly for the bloc, it appears that Germany, the Netherlands, France and Italy had originally been looking to do a deal with AstraZeneca in May alongside the UK – but were blocked by the EU, which insisted it take over negotiations. 

According to ITV’s Robert Peston: ‘The extra talks with the European Commission led to no material changes to the contract, but wasted time on making arrangements to make the vaccine with partner sites.’

The delays in producing the vaccine are now thought to be due to under-production at one of those sites, located in Belgium. 

Explaining the delay in more detail, Soriot said the process involves pumping the virus into large vats of live cultures which then generate the vaccine.

Die Zeit, one of Germany's best-respected broadsheets, ran with the headline 'the best advert for Brexit' while accusing the EU of being 'slow and bureaucratic'

Die Zeit, one of Germany’s best-respected broadsheets, ran with the headline ‘the best advert for Brexit’ while accusing the EU of being ‘slow and bureaucratic’ 

Meanwhile Bild newspaper accused Von Der Leyen of shirking blame and wasting time, while adding that 'Brexit Brits' have escaped the crisis

Meanwhile Bild newspaper accused Von Der Leyen of shirking blame and wasting time, while adding that ‘Brexit Brits’ have escaped the crisis

Pascal Soriot, the chief of vaccine-maker AstraZeneca, accused the EU of being 'emotional' over the delay to its jabs while also pointing the finger of blame at a three-month delay in ordering vaccines

Pascal Soriot, the chief of vaccine-maker AstraZeneca, accused the EU of being ’emotional’ over the delay to its jabs while also pointing the finger of blame at a three-month delay in ordering vaccines

Because the process involves living things and many variables, the exact quantity of product is difficult to predict ahead of time – some vats will produce more, some less, and it takes time and a lot of tweaking to get all of them running at full capacity.

Germany denies claim AstraZeneca vaccine doesn’t work for OAPs  

The German health ministry says the claim that the Oxford/AstraZeneca Covid vaccine doesn’t work in elderly people was untrue and there is ‘no data’ to support it

Scientists slammed the spurious claim overnight after it was published by German newspaper Handelsblatt, which said government sources had warned the jab only appeared to be eight per cent effective but didn’t publish any data to prove it.

Oxford University rubbished the report, saying there was ‘no basis’ for the allegation, and that their data has already been ‘released transparently’.

AstraZeneca, manufacturing the jab on behalf of Oxford, said it was ‘completely incorrect’.

And scientists added they had ‘no idea’ where the figure has come from, adding that it was not proved by research on the vaccine.

Germany has now confirmed there is no data to suggest the effectiveness of the vaccine is that low and that the European Medicines Agency will decide whether to approve the jab on Friday.

It is not clear where the eight per cent figure emerged, with a political correspondent at the German paper saying senior sources in the government had given it to him without scientific data.

‘A very efficient vaccine factory can produce up to three times the same as a less efficient factory… as happened at one of our European sites,’ Soriot added. 

Faced with growing public anger over the failings, Italy has threatened to sue to get its vaccine doses while Von Der Leyen has ordered AstraZeneca to ‘meet your obligations.’

But, according to Soriot, the company is meeting its obligations because it only signed a ‘best effort’ deal with the EU – promising to try and achieve 300million vaccines, but with both sides acknowledging that the process might be hit by delays.

‘We are two months behind schedule,’ Soriot admitted. ‘But we are working to solve these problems.’

He also put paid to rumours circulated by German ministers – and printed in two newspapers – that his vaccine barely works in old people as ‘silly nonsense’.

‘I don’t know where that figure comes from. It’s totally wrong,’ he said. ‘Political maneuvers? I don’t know. 

‘Of course, like tests and masks, vaccines have also become a political tool. But bogus reconstructions like these are shameful because they only swell the Anti-Vax movement and confuse people. At the moment we should all be united.’

As a final note, he said the vaccine is being distributed on a not-for-profit basis, meaning any allegations that countries have paid to skip the queue are untrue. 

AstraZeneca had been due to hold another meeting with EU chiefs to discuss the supply problems but pulled out of the summit at the last minute, according to Politico.

The company instead intends to reply to all concerns in writing, an official at the EU commission said. 

That means, at least for now, it appears the EU has little choice but to sit and wait as the UK and US vaccine programmes ramp up while its own effort trails behind.

Europe has been hit harder than any continent with coronavirus, suffering some 29.3million cases in total compared to second-place North America’s 29million.

Meanwhile the continent has amassed some 670,000 deaths compared to 610,000 in North America.

While leaders were praised for their handling of the first wave of virus, Europe has been hit badly with a second winter wave that a mish-mash of tiered systems and full lockdowns has largely failed to control.

The circulation of new and more-potent variants of the virus have further added to the continent’s woes, with experts warning that vaccination is now the best path out of the crisis.

These set of graphs show the number of vaccines ordered by the UK and the EU. The EU has also ordered a number of other vaccines, including 300million Sanofi-GSK doses and 405million CureVac doses

These set of graphs show the number of vaccines ordered by the UK and the EU. The EU has also ordered a number of other vaccines, including 300million Sanofi-GSK doses and 405million CureVac doses

Since approving both the Pfizer and AstraZeneca vaccine last year, the UK has managed to rapidly scale up its vaccine drive – and will soon have vaccinated some 30million people with all over-50s jabbed by March.

By contrast, the EU has vaccinated just 5million in total with 1.8million of those in economic powerhouse Germany.

That means Germany has vaccinated roughly 2 in 100 of its population since its vaccine roll-out began a month ago, while Israel vaccinates the same proportion of its population every single day.

The continent is now facing the grim reality that it will be March before its vaccine campaign can properly get underway, by which time the UK’s campaign will be almost halfway complete. 

‘The thing slipped away from us,’ Angela Merkel admitted on Sunday, according to a separate article on Bild hitting out at the Chancellor.

Meanwhile Markus Soder, the Prime Minister of Bavaria, was also forced to admit: ‘The fact is: something must have gone wrong. 

‘Either too little was ordered, which is why the order was placed again – obviously too bureaucratic…

‘We are a pharmaceutical country, an industrial giant. It must be possible that more can be done.

‘The only thing that worries me is that other countries seem to have ordered faster and more efficiently.’ 

‘Leaving was the right thing to do’: Brexiteers claim EU vaccine chaos PROVES UK made the right decision to split from the bloc as AstraZeneca boss reveals Brussels ordered jabs THREE MONTHS after the UK

Brexiteers have seized on the EU’s vaccine chaos and claimed it proves the UK was right to split from the bloc as the chief executive of AstraZeneca revealed Brussels ordered its jabs three months after Britain.      

The European Commission has threatened to block vaccine exports amid growing criticism of a slow rollout on the continent.  

European health commissioner Stella Kyriakides accused AstraZeneca, which works with Oxford University on its vaccine, of failing to give a valid explanation for failing to deliver doses to the bloc.

But AstraZeneca CEO Pascal Soriot hit back and claimed the EU was being ’emotional’. 

German media unleashed on EU bureaucrats on Wednesday over the continent's painfully-slow vaccine roll-out (pictured, a graph showing which countries are vaccinating fastest)

German media unleashed on EU bureaucrats on Wednesday over the continent’s painfully-slow vaccine roll-out (pictured, a graph showing which countries are vaccinating fastest) 

He said ‘the UK contract was signed three months before the European vaccine deal’ which meant there had been an ‘extra three months to fix all the glitches’ in Britain while for Europe ‘we are three months behind in fixing those glitches’.

Eurosceptics said the EU delay on agreeing a contract was ‘absurd’ and evidence the UK is better off as an independent nation. 

Nigel Farage, the leader of the Reform UK Party, said: ‘Once vaccines were approved, the British government were very, very quick to act. 

‘In contrast the EU dithered and delayed. Why? Well, of course, it is a bureaucratic process, a grinding machine that can’t do anything quickly and they are always obsessed with something called the precautionary principle which makes it very difficult to get anything new out to consumers. 

‘Fast forward to where we are now since the UK made that decision and I am pleased to say that 10 per cent of the population have now been vaccinated, hopefully we are going to be on target to get the vaccinated by the time Valentine’s Day comes along. 

‘So 10 per cent of the UK has been vaccinated. In the EU the figure is two per cent and that is leading to huge criticism of the European Commission. They are the ones that really make the big decisions.’ 

Mr Farage said the vaccines situation proved the EU is a ‘bad project, run by bad people’ and added: ‘Brexit was the right thing to do.’ 

Tory MP Peter Bone told MailOnline: ‘Do you remember the criticism we faced for not joining the EU vaccination programme?

‘We made the right call as an independent nation and it is clear it was a benefit to us not being tied to the bureaucracy of the EU. 

‘A three month delay is absurd. It is clearly an advantage to not be part of the EU and it is really good for us but sad obviously for the people of the countries of the EU.’

Mr Soriot said in an interview with the Italian newspaper La Repubblica that there had been ‘teething issues’ in the rollout of the vaccine both in the UK and on the continent. 

He said: ‘But the UK contract was signed three months before the European vaccine deal. 

‘So with the UK we have had an extra three months to fix all the glitches we experienced. 

‘As for Europe, we are three months behind in fixing those glitches. Would I like to do better? Of course. But, you know, if we deliver in February what we are planning to deliver, it’s not a small volume. We are planning to deliver millions of doses to Europe, it is not small.’ 

Mr Soriot said the UK had got a ‘head start’ on its vaccine deal because the Government was already working with Oxford University.

He also dismissed suggestions the firm was selling jabs to other countries to make more money as he said ‘we make no profit everywhere’. 

He said all governments ‘are under pressure’ because of the coronavirus crisis and ‘everybody is getting kind of a bit, you know, aggravated or emotional about those things’. 

Boris Johnson has said he has ‘total confidence’ in the UK’s supply of vaccines after the EU threatened to impose controls on the export of jabs.

HOW DO THE OXFORD, MODERNA AND PFIZER/BIONTECH VACCINES COMPARE? 

Moderna and Pfizer/BioNTech have both released interim results of the final stage clinical trials of their vaccines, with both suggesting they are extremely effective. 

Oxford University has published the findings from its second phase, which show the jab provokes an immune response and is safe to use – it is not yet clear how well it protects against coronavirus in the real world.

Here’s how they compare: 

PFIZER (US) & BIONTECH (DE)

mRNA vaccine – Genetic material from coronavirus is injected to trick immune system into making ‘spike’ proteins and learning how to attack them.

mRNA vaccine – both Moderna’s and Pfizer and BioNTech’s vaccines work in the same way.

Recombinant viral vector vaccine – a harmless cold virus taken from chimpanzees was edited to produce the ‘spike’ proteins and look like the coronavirus.

94.5% effective (90 positive in placebo group, 5 positive in vaccine group) .

95% effective (160 positive in placebo group, 8 positive in vaccine group).

62% – 90% effective, depending on dosing. Average 70.4%.

Moderna confirmed it will charge countries placing smaller orders, such as the UK’s five million doses, between £24 and £28 per dose. US has secured 100million doses for $1.525billion (£1.16bn), suggesting it will cost $15.25 (£11.57) per dose.

The US will pay $1.95bn (£1.48bn) for the first 100m doses, a cost of $19.50 (£14.80) per dose.

Expected to cost £2.23 per dose. The UK’s full 100m dose supply could amount to just £223million.

UK has ordered five million doses which will become available from March 2021. Moderna will produce 20m doses this year, expected to stay in the US. 

UK has already ordered 40million doses, of which 10million could be available in 2020. First vaccinations expected in December.

UK has already ordered 100million doses and is expected to be first in line to get it once approved.

What side effects does it cause? 

Moderna said the vaccine is ‘generally safe and well tolerated’. Most side effects were mild or moderate but included pain, fatigue and headache, which were ‘generally’ short-lived. 

Pfizer and BioNTech did not produce a breakdown of side effects but said the Data Monitoring Committee ‘has not reported any serious safety concerns’.

Oxford and AstraZeneca said there are no serious safety concerns about the vaccine. Phase three trial saw three out of 23,745 participants have ‘serious adverse events’ that were ‘possibly’ linked to the vaccine. All three have recovered or are recovering, and remain in the trial.